I think most of the LT holders came to the logical conclusion that the BOD would have to be pretty dumb not only to be called out twice on a deal possibly disadvantageous to MGC but also making sensitive announcements prematurely that could be interpreted now as being misleading. Its just blind faith to expect that the board is capable of performing appropriate due diligence after the debacle over the VC deal. (To not receive the $1 mio deposit on the signing of the VC deal as an act of good faith when supposedly VC had multi millions at its disposal is reprehensible). I say blind faith because we know absolutely nothing about Cannaglobal in just about every respect and they are showing discourtesy to SH's by not providing more info about them.
I'm not going to go as far as saying that MXC SH's will not benefit out of whatever does finally get announced, but I'm hoping that they don't make another miscalculation. Even if they do it just sets them up for a cheap TO.
- Forums
- ASX - By Stock
- RGT
- Ann: Voluntary Suspension Extension
Ann: Voluntary Suspension Extension, page-53
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
|
|||||
Last
30.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.00M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3300 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 313 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3300 | 0.310 |
2 | 3844 | 0.290 |
2 | 20000 | 0.270 |
1 | 4000 | 0.250 |
1 | 17426 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 313 | 1 |
0.305 | 45198 | 3 |
0.315 | 2825 | 2 |
0.340 | 2115 | 2 |
0.370 | 1056 | 1 |
Last trade - 16.16pm 12/07/2024 (20 minute delay) ? |
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RGT (ASX) Chart |
Day chart unavailable